Skip to main content

Renal-Cell Carcinoma

Renal-Cell Carcinoma, Conference Highlights ASCO
Adjuvant Pembrolizumab Therapy Significantly Extends Disease-Free Survival in Patients with Clear-Cell Renal-Cell Carcinoma
Phoebe Starr
Phoebe Starr
Read More
Renal-Cell Carcinoma
Avelumab plus Axitinib New First-Line Standard of Care in Advanced Renal-Cell Carcinoma
Chase Doyle
Chase Doyle
Read More
Renal-Cell Carcinoma
First-Line Treatments for Metastatic Renal-Cell Carcinoma Are Evolving
Read More
Renal-Cell Carcinoma
Tivozanib Outperforms Sorafenib as First-Line Treatment in Advanced Renal-Cell Carcinoma
Read More
Renal-Cell Carcinoma
Axitinib Dose Titration Up Enhances Outcomes in Metastatic Renal-Cell Carcinoma
Wayne Kuznar
Read More
Renal-Cell Carcinoma
Quality of Life Drives Patient Preference for Metastatic RCC Drug
Wayne Kuznar
Read More

Results 1 - 6 of 6